FUJIFILM Toyama Chemical

FUJIFILM Toyama Chemical focuses on developing new drugs to address unmet medical needs. The company has been developing innovative diagnostic and therapeutic radiopharmaceuticals, as well as treatments with unique mechanisms of action in the fields of cancer, central nervous system diseases, and infectious diseases, where significant unmet medical needs remain. We are also committed to leveraging Drug Delivery System (DDS) technology to develop new drugs aimed at delivering the required amount of medication to specific parts of the body in a timely manner. By exploring synergies with in vitro diagnostic devices and reagents owned by Fujifilm Group companies, the company will expand its range of integrated solutions from diagnosis to treatment.